In both the TCGA glioma and CGGA glioma, samples with strong CD44 transcription are primarily having wild-type IDH, but the ones with low CD44 expression have IDH mutation (Figures 1D,E), which can also be discovered among GBM groups (Supplementary Figures 3A,C). This evidence concerns the gene IDH1 and central nervous system cancer.